Lumenis has obtained the US Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare (MHLW) approvals for its Array LaserLink pattern scanning device for multi-spot laser photocoagulation for use during retinal surgery.
The pattern scanning device provides greater predictability in retinal treatments and presumably less collateral damage to the retina.
The shorter pulse duration and sequential multi-spot delivery of the laser used in the new system will reduce patient discomfort and will also reduce treatment time for clinicians.
Array LaserLink features an examination slit lamp for use as a therapeutic laser delivery device and the device offers a variety of features when attached to a compatible Lumenis photocoagulator.
The device controls treatment parameters and micromanipulation using a remote touchpad designed to enhance the physician’s workflow and efficiency.
The Array LaserLink device is indicated for the variety of ophthalmic uses specified for the laser to which it is attached, including diabetic retinopathy, choroidal neovascularization, branch retinal vein occlusion, retinal tears and detachments.
With the Array LaserLink device, compatible Lumenis lasers systems will be augmented with the Multi-spot patterns, Multi-wavelength compatibility, Continuous Variable Spot Size and Variable distance between spots features.